Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Undiagnosed Diseases Network, |
RCV000533476 | SCV000622156 | pathogenic | Capillary malformation; Sturge-Weber syndrome | 2016-07-19 | criteria provided, single submitter | clinical testing | This variant has been described in multiple affected individuals with a mosaic etiology (PMID 26778290) |
Equipe Genetique des Anomalies du Developpement, |
RCV001526543 | SCV001736968 | pathogenic | Hemangiomatosis | criteria provided, single submitter | clinical testing | ||
Equipe Genetique des Anomalies du Developpement, |
RCV001526638 | SCV001737069 | pathogenic | Angioosteohypertrophic syndrome | criteria provided, single submitter | clinical testing | ||
Institute of Medical and Molecular Genetics, |
RCV001705695 | SCV001934206 | pathogenic | Segmental undergrowth associated with capillary malformation | 2021-04-06 | criteria provided, single submitter | clinical testing | |
Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV002254275 | SCV002525658 | pathogenic | not provided | 2021-08-01 | criteria provided, single submitter | clinical testing | This variant is a recurrent pathogenic variant that accounts for ~90% of individuals with non-syndromic port-wine stains and Sturge-Weber syndrome (MIM: 185300), which, along with congenital capillary malformations (MIM: 163000), is included within GNAQ-related disorder (PMID: 25374402, PMID: 23656586). |
Institute of Human Genetics, |
RCV002294003 | SCV002587081 | likely pathogenic | Familial multiple nevi flammei | 2022-10-07 | criteria provided, single submitter | clinical testing | _x000D_ Criteria applied: PS3, PS4_MOD, PM2_SUP, PP3 |
Clinical Genomics Laboratory, |
RCV000043593 | SCV004176929 | pathogenic | Capillary malformation | 2023-10-14 | criteria provided, single submitter | clinical testing | A GNAQ c.548G>A (p.Arg183Gln) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals affected with Sturge-Weber syndrome, nonsyndromic port-wine stains, and phakomatosis pigmentovascularis with capillary malformation and hemihypertrophy (Shirley MD et al., PMID: 23656586; Nakashima M et al., PMID: 25374402; Frigerio A et al., PMID: 26192947; Thomas AC et al., PMID: 26778290; He R et al., PMID: 32613723). This variant has been reported in the ClinVar database as a pathogenic/likely pathogenic variant by multiple submitters (ClinVar ID: 50853), and it has been reported in multiple cases in the cancer database COSMIC (Genomic ID: COSV54106047). This variant is absent from the general population (gnomAD v.3.1.2), indicating it is not a common variant. This variant resides within the GTP-binding site of the G2 motif, which is defined as a critical functional domain (Nakashima M et al., PMID: 25374402). Computational predictors indicate that the GNAQ c.548G>A (p.Arg183Gln) variant is damaging, evidence that correlates with impact on GNAQ function. In support of this prediction, functional studies show that this variant increases activation of the mitogen-activated protein kinase (MAPK) pathway and increases angiopoietin-2 expression (Shirley MD et al., PMID: 23656586; Huang L et al., PMID: 34670408). GNAQ is a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease. Based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868), the GNAQ c.548G>A (p.Arg183Gln) variant is classified as pathogenic. |
OMIM | RCV000043592 | SCV000071610 | pathogenic | Sturge-Weber syndrome | 2014-12-01 | no assertion criteria provided | literature only | |
OMIM | RCV000043593 | SCV000071611 | pathogenic | Capillary malformation | 2014-12-01 | no assertion criteria provided | literature only | |
Dave Chen Lab, |
RCV003221795 | SCV003914813 | uncertain significance | Melanoma | 2023-03-28 | no assertion criteria provided | research | Somatic variant identified in a melanoma arising in a patient with Tatton-Brown Rahman Syndrome |